Infliximab for the treatment of Ipilimumab (anti CTLA-4) and Nivolumab/Pembrolizumab (anti PD-1) associated colitis

M. Sidhu, T. Mersaides, E. Liniker, D. Tate, G. Long, A. Nagrial, V. Kariyawasam, N. Sandanyake, R. Kefford, M. Carlino, V. Kwan

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)139
Number of pages1
JournalJournal of Gastroenterology and Hepatology (Australia)
Issue numberSupplement s3
Publication statusPublished - Sep 2015
Externally publishedYes

Cite this